A standardized framework resolves ambiguity in motor neuron loss across neurodegenerative diseases

Abstract

Abstract Motor neuron (MN) loss is a hallmark of neurodegenerative disorders, yet its assessment remains variable, confounding mechanistic and therapeutic interpretation. To address this, we conducted a systematic review and meta-analysis of spinal muscular atrophy (SMA) mouse studies, revealing 60% variability in reported MN loss, largely attributable to nonspecific spinal cord sampling. Using a whole-segment approach with tissue clearing, MN tracing, and multimodal imaging, we confirmed segment-dependent differences in MN counts. Common MN markers (SMI-32, Nissl) lacked specificity, whereas choline acetyltransferase (ChAT) provided robust labeling in murine and human spinal cords. Deep learning–based whole-mount segmentation enabled unbiased MN quantification and validated manual counts. Integrating analysis with computational modeling established segment sampling as a key driver of variability and revealed degeneration patterns: widespread MN loss in amyotrophic lateral sclerosis (ALS), selective MN loss in severe SMA, and preservation in mild SMA models. These findings establish a framework for reproducible MN quantification. Highlights Spinal cord segment-specific analysis reduces variability and allows accurate MN quantification ChAT is the most reliable MN marker in murine and human spinal cords Deep learning–based segmentation enables unbiased MN quantification in intact spinal cords MN degeneration is widespread in ALS but restricted to pools innervating proximal muscles in severe SMA

The authors' abstract, as published at the source. Acta Neuropathologica Communications, 2026 · DOI ↗